Retatrutide met primary and key secondary endpoints in a 2339-participant, randomized, double-blind, placebo-controlled phase 3 trial, demonstrating clinically meaningful weight reduction across 4, 9, ...

Daniel is a 27-year-old List Writer for Collider living in the south suburbs of Chicago, Illinois. As an avid film buff, he watches and analyzes many films and TV shows, especially in the horror genre ...

It's imperative to mod Total War Warhammer 3 for the best experience. The strategy game is an impressive beast even if you just play vanilla, but a handful of crucial mods make things feel a lot ...

Brepocitinib is a first-in-class, oral, selective TYK2–JAK1 inhibitor that blocks cytokine signaling, which has been implicated in dermatomyositis. In this phase 3, double-blind, randomized, ...

Jeremy has more than 2500 published articles on Collider to his name, and has been writing for the site since February 2022. He's an omnivore when it comes to his movie-watching diet, so will gladly ...

A phase 3 study of Gossamer Bio’s seralutinib in pulmonary arterial hypertension (PAH) has missed its primary endpoint, triggering a 77% crash in the biotech’s share price. The company has paused ...

Compass Pathways has announced that its investigational psilocybin treatment has successfully met its primary endpoint in a second Phase 3 clinical trial moving it one step closer to FDA submission.

Altimmune closed a $75M direct offering to fund Phase 3 pemvidutide trials for MASH, leveraging recent positive Phase 2b data and FDA Breakthrough Therapy status. Pemvidutide’s dual GLP-1/glucagon ...

Both dosage regimens of amlitelimab were associated with statistically significant improvements in skin clearance and disease severity vs placebo in the US estimand. Topline data were announced from ...

If you needed an excuse to revisit The Witcher 3 before hype starts for The Witcher 4 in earnest — well, reportedly, CD Projekt Red has you covered. There is increasing evidence that the developer ...

There aren’t as many horror movies streaming now as there were in the Halloween season, but there’s enough to get your scare on. This month, contemporary horror films are making a strong showing, ...

(RTTNews) - SELLAS Life Sciences Group Inc. (SLS) reported that survival in its pivotal Phase 3 REGAL trial is extending longer than anticipated, delaying the occurrence of the 80th event required to ...